$ZBH

Ivan Tornos

Zimmer Biomet

Chairman, President & CEO • Since 2023 • Health Care

📊 CEO Reputation Score

FY2025 vs FY2024 · Source: SEC EDGAR filings

36/100

Blend of this company's year-over-year free-cash-flow and profit improvement, each ranked as a percentile against every scored company in the three indexes.

Free cash flow: $1.3B → $1.5B (+13.7% YoY) — fiscal 2025 vs fiscal 2025
Profit (net income): $904M → $705M (−22.0% YoY) — fiscal 2025 vs fiscal 2024

How this score works · S&P 500 reputation leaderboard

Overview

Ivan Tornos is the chairman, president & ceo of Zimmer Biomet since 2023. Zimmer Biomet is a Health Care company headquartered in Warsaw, Indiana, founded in 1927, and one of the 500 companies in the S&P 500 — every one of which is profiled on this site.

Leadership

Ivan holds the chief executive role at Zimmer Biomet with the title Chairman, President & CEO — in post since 2023. This page is the concise leadership record for Zimmer Biomet in the S&P 500 CEO index; the site's fully researched long-form profiles (career timelines, education, achievements, setbacks, philosophy and sourced quotes) currently cover the index's ten largest companies, and this entry will be expanded in the same format.

At a Glance

Sector: Health Care
Ticker: $ZBH
Headquarters: Warsaw, Indiana
Founded: 1927
CEO since: 2023
Index: S&P 500 (#499 of 500)